Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

Ansell Limited (ASX:ANN) Up 39% in a Year: What the FY26 Result Shows

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

EBOS Group Limited (ASX:EBO) Down 41.05% Over 12 Months: FY26 Results in Context

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Fisher & Paykel Healthcare Corporation (ASX:FPH): One-Year Share Performance and the Updated FY27 Guidance Details

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Integral Diagnostics (ASX:IDX) Shares Down 21% in a Year: Reading the FY26 Numbers

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Mesoblast (ASX:MSB) Down 24% in 12 Months: Ryoncil Revenue and FY26 Update in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Nanosonics (ASX:NAN) Down 34% Year on Year: FY26 Results and CORIS Launch Plans in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Neuren Pharmaceuticals (ASX:NEU) Down 5% Over the Year: H1 2026 Royalty and Pipeline Update in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Pro Medicus (ASX:PME) Down 48% in a Year: FY26 Results Revisited

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

PYC Therapeutics (ASX:PYC) Up 141% in 12 Months: Recent Financial Results in Focus

Across the broader market, the S&P/ASX 200 Health Careindex[XHJ] (INDEXASX: XHJ) stood at 31,982.20, up 0.63% (+200.50 points) as of 6 October, and is down 16% over the past year. Meanwhile, the S&P/ASX 200 stood at 8,735.70, up 0.57% (+49.30 points) at the same …

Sonal Goyal | 06 October 2026

Peet Limited (ASX:PPC) Shares Trail Over the Year - What’s Next for the Stock?

For context, the S&P/ASX 200 Real Estateindex[XRE] (INDEXASX: XRE) stood at 3,202.90, up 1.11% (+35.20 points) in today’s session as of 6 Oct, 4:45 pm, and is down nearly 22% over the past year.

Sonal Goyal | 06 October 2026
Support

Hi! How can we help you today?

Loading…